Cellebrite DI Ltd.CLBTNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +17.24% | +20.06% | +18.35% | +17.94% | +18.13% |
| Gross Profit Growth | +17.07% | +18.00% | +20.32% | +15.64% | +19.37% |
| EBITDA Growth | +4.78% | +24.92% | +12.92% | +22.31% | +34.08% |
| Operating Income Growth | +4.85% | +32.67% | +15.46% | -2.34% | +32.29% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +10.34% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +4.96% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +8.47% |
| Weighted Average Shares Growth | +19.96% | +26.29% | +20.81% | +20.92% | +13.94% |
| Weighted Average Shares Diluted Growth | +27.21% | +26.66% | +25.15% | +19.65% | +1.68% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +50.51% | +107.93% | +124.51% | -20.12% | +24.65% |
| Free Cash Flow Growth | +58.56% | +134.05% | +138.26% | -24.81% | +26.96% |
| Receivables Growth | +6.59% | +31.63% | +31.72% | +11.17% | +27.46% |
| Inventory Growth | -10.07% | -3.13% | +8.57% | -11.07% | -14.95% |
| Asset Growth | +29.59% | +34.16% | +41.47% | +32.59% | +35.95% |
| Book Value per Share Growth | +718.76% | +0.00% | +0.00% | +24.11% | +26.50% |
| Debt Growth | -22.37% | -18.12% | +91.26% | +74.68% | +106.67% |
| R&D Expense Growth | +17.69% | +17.59% | +20.76% | +8.48% | +16.66% |
| SG&A Expenses Growth | +21.17% | +15.13% | +21.49% | +27.27% | +16.69% |